Results 31 to 40 of about 20,408 (237)

Development of diethylcarbamazine-loaded poly(caprolactone) nanoparticles for anti-inflammatory purpose: Preparation and characterization

Brazilian Journal of Pharmaceutical Sciences, 2022
Diethylcarbamazine-loaded nanoparticles were previously evaluated for their anti-inflammatory activity. However, little is known regarding their physicochemical properties.
Henrique Rodrigues Marcelino, Brennda Martins Gabinio, Marine Nascimento de Lima, Silvana Cartaxo da Costa Urtiga, Gabriel Barros Rodrigues, Bruna Braga Dantas, Demétrius Antônio Machado de Araújo, Christina Alves Peixoto, Elquio Eleamen Oliveira   +8 more
doaj   +1 more source

Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Cote d\u27Ivoire [PDF]

, 2019
BackgroundA single co-administered dose of ivermectin (IVM) plus diethylcarbamazine (DEC) plus albendazole (ALB), or triple-drug therapy, was recently found to be more effective for clearing microfilariae (Mf) than standard DEC plus ALB currently used ...
Bjerum, Catherine M, Chhonker, Yashpal S, Edi, Constant, King, Christopher L, Koudou, Benjamin G, Meite, Aboulaye, Murry, Daryl J, Ouattara, Allassane F, Penali, Louis K, Weil, Gary J   +9 more
core   +3 more sources

Mass drug administration coverage evaluation survey for lymphatic Filariasis in Bagalkot and Gulbarga districts

Indian Journal of Community Medicine, 2012
Background: Lymphatic filariasis (LF) is endemic in 83 countries and territories, with more than a billion people at risk of infection. In view with the global elimination, mass drug administration (MDA) with single dose of diethylcarbamazine and ...
Prakash Kurubarahalli Patel
doaj   +1 more source

Tuberculosis manifesting with significant peripheral eosinophilia: A case report and review of literature

Clinical Case Reports, Volume 11, Issue 10, October 2023., 2023
Chest x‐ray showing diffuse nodular calcifications in both lungs, innvolving all zones. Key Clinical Message Peripheral eosinophilia is a rare but potential sign of TB infection. Physicians should assess patients for TB, especially if they display related symptoms or risk factors, and consider TB as a differential diagnosis, especially in idiopathic ...
Abhiram Rao Damera, Prakash Gupta, Shaheer Farooqi, Vivek Sanker, Arpita Mariam Mathews, Shreya Pampati, Manoj Reddy Allala, Tirth Dave   +7 more
wiley   +1 more source

Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approach [PDF]

, 2019
BACKGROUND: The World Health Organization (WHO) currently recommends height or age-based dosing as alternatives to weight-based dosing for mass drug administration lymphatic filariasis (LF) elimination programs.
Dubray, Christine, Fischer, Peter U, Goss, Charles W, Hardy, Myra, Jambulingam, Purushothaman, King, Christopher L, Laman, Moses, Lemoine, Jean Frantz, O\u27Brian, Katiuscia, Robinson, Leanne J, Samuela, Josaia, Schechtman, Kenneth B, Subramanian, Swaminathan, Supali, Taniawati, Weil, Gary J   +14 more
core   +2 more sources

A case report on rare finding of microfilaria in pus sample of an ulcer over elephantiasis leg

Clinical Case Reports, Volume 11, Issue 10, October 2023., 2023
Direct visualization of microfilaria under microscope from pus sample. Key Clinical Message Skin ulcerations are a significant cause of morbidity and can be challenging to manage. Among the various causes of chronic non‐healing ulcers, lymphedema is also considered a possible diagnosis in countries such as Nepal.
Manoj Adhikary, Kshitiz Pandey, Sadikchya Lamichhane, Pratik Pandey   +3 more
wiley   +1 more source

Efficacy of High-Dose Albendazole with Ivermectin for Treating Imported Loiasis, Italy

Emerging Infectious Diseases, 2019
We describe the outcomes of 16 cases of imported loiasis in Italy. Patients had microfilaremia
Federico Gobbi, Dora Buonfrate, Francesca Tamarozzi, Monica Degani, Andrea Angheben, Zeno Bisoffi   +5 more
doaj   +1 more source

Comparison of different drug regimens for the treatment of loiasis-A TropNet retrospective study. [PDF]

PLoS Neglected Tropical Diseases, 2018
BACKGROUND:Loa loa infection is endemic in limited areas of West-Central Africa. Loiasis has been associated with excess mortality, but clinical studies on its treatment are scant, particularly outside endemic areas, due to the rarity of cases diagnosed.
Federico Gobbi, Emmanuel Bottieau, Olivier Bouchaud, Dora Buonfrate, Fernando Salvador, Gerardo Rojo-Marcos, Paola Rodari, Jan Clerinx, Begoña Treviño, Juan Paulo Herrera-Ávila, Andreas Neumayr, Guido Calleri, Andrea Angheben, Camilla Rothe, Lorenzo Zammarchi, Massimo Guerriero, Zeno Bisoffi   +16 more
doaj   +1 more source

Economic Costs and Benefits of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India [PDF]

, 2016
Lymphatic filariasis afflicts 68 million people in 73 countries, including 17 million persons living with chronic lymphedema. The Global Program to Eliminate Lymphatic Filariasis aims to stop new infections and to provide care for persons already ...
Addiss, David, Fox, LeAnne, Rout, Jonathan, Sawers, Larry, Stillwaggon, Eileen   +4 more
core   +2 more sources

Lymphatic Filariasis Control in Tanzania: Effect of Six Rounds of Mass Drug Administration with Ivermectin and Albendazole on Infection and Transmission. [PDF]

, 2013
Control of lymphatic filariasis (LF) in most countries of sub-Saharan Africa is based on annual mass drug administration (MDA) with a combination of ivermectin and albendazole, in order to interrupt transmission. We present findings from a detailed study
C Chaccour, DJ Tisch, DW Meyrowitsch, DW Meyrowitsch, DW Meyrowitsch, E Michael, E Michael, E Michael, EM Pedersen, Erling M Pedersen, FO Richards, GJ Weil, GJ Weil, GJ Weil, H Joseph, HM Joseph, JD King, JE McMahon, JE McMahon, JL Liang, JM Mlandonicky, KC Kobylinski, KD Ramaiah, KY Won, LM Zeldenryk, M Parker, MN Malecela, Mwele N Malecela, N Kolstrup, O Mitja, Paul E Simonsen, PE Simonsen, PE Simonsen, PE Simonsen, PE Simonsen, PE Simonsen, PE Simonsen, PE Simonsen, PE Simonsen, PE Simonsen, PJ Hotez, RMR Ramzy, RT Rwegoshora, Stephen M Magesa, WHO, WHO, William N Kisinza, YA Derua, Yahya A Derua   +48 more
core   +1 more source